2007
DOI: 10.1016/j.yjmcc.2006.10.014
|View full text |Cite
|
Sign up to set email alerts
|

Preconditioning protects endothelium by preventing ET-1-induced activation of NADPH oxidase and xanthine oxidase in post-ischemic heart

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
39
0

Year Published

2007
2007
2017
2017

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 44 publications
(40 citation statements)
references
References 43 publications
1
39
0
Order By: Relevance
“…Currently, all available evidence related to COPD mechanisms firmly suggests that oxidative stress plays a significant role in the pathogenesis of COPD [6]. ET-1 stimulates the production of superoxide via NADPH oxidase activation, and, conversely, reactive oxygen species appear to stimulate ET-1 production [36]. The prevention of decrease in antioxidant activity upon intervention with ET-1 receptor antagonists suggests that ET-1 is involved in the pathophysiological pathway of oxidative stress in the development of emphysema.…”
Section: Discussionmentioning
confidence: 99%
“…Currently, all available evidence related to COPD mechanisms firmly suggests that oxidative stress plays a significant role in the pathogenesis of COPD [6]. ET-1 stimulates the production of superoxide via NADPH oxidase activation, and, conversely, reactive oxygen species appear to stimulate ET-1 production [36]. The prevention of decrease in antioxidant activity upon intervention with ET-1 receptor antagonists suggests that ET-1 is involved in the pathophysiological pathway of oxidative stress in the development of emphysema.…”
Section: Discussionmentioning
confidence: 99%
“…The results from that study indicated corresponding increases in mast cell secretory products (i.e., histamine or tumor necrosis-␣) in response to oxidants perfused through isolated hearts and that mast cell stabilizers blocked this release. More recent reports have demonstrated that treatment of ischemic myocardium with either selective (ET A , BQ-123) or nonselective (ET A -ET B , bosentan) receptor antagonism significantly reduced catalase and superoxide dismutase activity as well as glutathione content (20,27,41). Indeed, our preliminary data (n ϭ 3/group) reveals a significant reduction in the LV tissue levels of malonyl-CoA dehydrogenase at 3 days postsurgery in ETA-treated fistula animals compared with untreated fistula values (791 Ϯ 72 vs. 1,380 Ϯ 168 nM malondialdehyde/wet LV tissue weight, Fist ϩ ETA vs. Fist respectively, P Յ 0.05).…”
Section: Effect Of Et a Receptor Antagonism On Postfistula Remodelingmentioning
confidence: 97%
“…In the fourth protocol, the HKS-induced constrictions of the epineurial arterioles were studied in the absence and presence of SOD (120 U/ml) alone, catalase alone (5,000 U/ml), SOD (120 U/ml) plus catalase (5,000 U/ml), tempol (a cell membrane-permeable superoxide scavenger; 10 Ϫ4 M) (8) In the fifth protocol, the effects of N -nitro-L-arginine methyl ester (L-NAME, an inhibitor of NO synthase; 10 Ϫ6 -3 ϫ 10 Ϫ5 M) on changes in the diameter of epineurial arterioles were studied under LKS conditions. Additionally, in the presence of L-NAME (10 Ϫ5 M), the effects of S-nitroso-N-acetylpenicillamine (SNAP, an NO donor; 10 Ϫ9 -10 Ϫ6 M) on changes in the diameter of epineurial arterioles were studied under LKS conditions.…”
Section: Methodsmentioning
confidence: 99%